» Authors » Shin-Ichiro Takashima

Shin-Ichiro Takashima

Explore the profile of Shin-Ichiro Takashima including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 34
Citations 378
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tada H, Okada H, Yoshida S, Shimojima M, Nomura A, Tsuda T, et al.
J Atheroscler Thromb . 2025 Jan; PMID: 39756983
Aim: We aimed to clarify the degree and factors associated with low-density lipoprotein (LDL)-cholesterol treatment target attainment among patients with heterozygous familial hypercholesterolemia (HeFH) using the Hokuriku-plus FH registry. Methods:...
2.
Goten C, Usui S, Takashima S, Inoue O, Yamaguchi K, Hashimuko D, et al.
Int J Mol Sci . 2023 Feb; 24(3). PMID: 36768190
Pulmonary arterial hypertension (PAH) remains a disease with poor prognosis; thus, a new mechanism for PAH treatment is necessary. Circulating nerve growth factor receptor (Ngfr)-positive cells in peripheral blood mononuclear...
3.
Mukai Y, Murai H, Hamaoka T, Sugimoto H, Inoue O, Goten C, et al.
Clin Auton Res . 2022 Jun; 32(4):229-235. PMID: 35737214
Purpose: Catheter ablation (CA) to isolate the pulmonary vein, which is an established treatment for atrial fibrillation (AF), is associated with left atrium reverse remodeling (LARR). The intrinsic cardiac autonomic...
4.
Goten C, Usui S, Takashima S, Inoue O, Okada H, Shimojima M, et al.
Pulm Circ . 2021 Mar; 11(1):2045894021990525. PMID: 33767850
Pulmonary arterial hypertension (PAH) remains a disease with a poor prognosis, so early detection and treatment are very important. Sensitive and non-invasive markers for PAH are urgently required. This study...
5.
Tada H, Okada H, Yoshida S, Shimojima M, Nomura A, Tsuda T, et al.
BMJ Open . 2020 Sep; 10(9):e038623. PMID: 32912992
Introduction: Familial hypercholesterolaemia (FH) is an autosomal-dominant inherited genetic disease. It carries an extremely high cardiovascular risk associated with significantly elevated low-density lipoprotein (LDL) cholesterol. The diagnostic rate of this...
6.
Hamaoka T, Murai H, Takata S, Hirai T, Sugimoto H, Mukai Y, et al.
J Cardiol . 2020 Jul; 76(6):573-579. PMID: 32620307
Background: Obstructive sleep apnea (OSA) is characterized by augmented sympathetic nerve activity. In our previous study, patients with OSA and an apnea-hyperpnea index (AHI)>55events/h showed increased single-unit muscle sympathetic nerve...
7.
Goten C, Usui S, Hamaoka T, Harada T, Inoue O, Okada H, et al.
J Cardiol Cases . 2020 May; 21(5):182-185. PMID: 32373243
The prognosis of pulmonary arterial hypertension (PAH) has significantly improved over the past two decades due to advances in medications, including pulmonary vasodilators. However, the side effects of these drugs...
8.
Okabe Y, Murai H, Tokuhisa H, Hamaoka T, Mukai Y, Sugimoto H, et al.
Auton Neurosci . 2020 Apr; 226:102671. PMID: 32272358
Background: Renal denervation is effective for modulating augmented sympathetic nerve activity (SNA) in heart failure with reduced ejection fraction (HFrEF). We have demonstrated that renal iodine-metaiodobenzylguanidine (I-MIBG) scintigraphy is associated...
9.
Inoue O, Usui S, Takashima S, Nomura A, Yamaguchi K, Takeda Y, et al.
Biochem Biophys Res Commun . 2019 Aug; 517(2):369-375. PMID: 31362891
Type 2 diabetes mellitus is an important risk factor for cardiovascular diseases (CVDs). Therapeutic angiogenesis using adipose-derived stem cells (ADSCs) is attractive for CVD therapy. However, although it would be...
10.
Chikata A, Kato T, Usuda K, Fujita S, Maruyama M, Otowa K, et al.
Heart Vessels . 2019 Apr; 34(10):1710-1716. PMID: 30972550
Phrenic nerve (PN) stimulation is essential for the elimination of PN palsy during balloon-based pulmonary vein isolation (PVI). Although ultrasound-guided vascular access is safe, insertion of a PN stimulation catheter...